Monitoring of patients with inherited metabolic disorders (IMDs) using dried blood spot (DBS) specimens has been routinely used since the inception of newborn screening (NBS) for phenylketonuria in the 1960s. The introduction of flow injection analysis tandem mass spectrometry (FIA-MS/MS) in the 1990s facilitated the expansion of NBS for IMDs. This has led to increased identification of patients who require biochemical monitoring. Monitoring of IMD patients using DBS specimens is widely favoured due to the convenience of collecting blood from a finger prick onto filter paper devices in the patient's home, which can then be mailed directly to the laboratory. Ideally, analytical methodologies with a short analysis time and high sample throughput are required to enable results to be communicated to patients in a timely manner, allowing prompt therapy adjustment. The development of ultra-performance liquid chromatography (UPLC-MS/MS), means that metabolic laboratories now have the capability to routinely analyse DBS specimens with superior specificity and sensitivity. This advancement in analytical technology has led to the development of numerous assays to detect analytes at low concentrations (pmol/L) in DBS specimens that can be used to monitor IMD patients. In this review, we discuss the pre-analytical, analytical and post-analytical variables that may affect the final test result obtained using DBS specimens used for monitoring of patients with an IMD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422991 | PMC |
| http://dx.doi.org/10.3390/ijns6020026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of metabolite stability in dried blood spot stored at different temperatures and times.
Sci Rep
December 2024
Metanotitia Inc, Building C4, Science and Technology Innovation Headquarters, Shenzhen (Harbin) Industrial Park, 288 Zhigu Street, Songbei District, Harbin, 150029, China.
Dried blood spot (DBS) sampling offers significant advantages over conventional blood collection methods, such as reduced sample volume, minimal invasiveness, suitability for home-based sampling, and ease of transport. However, understanding the effects of variable storage temperatures and times on metabolite stability is crucial due to varying intervals and delivery conditions between sample collection and metabolomics analysis. To minimize biological variances, all samples were collected from the same individual simultaneously and stored at three different temperatures (4 °C, 25 °C, and 40 °C) for diverse time points (3, 7, 14, and 21 days).
View Article and Find Full Text PDFN-Acetyltyrosine as a Biomarker of Parenteral Nutrition Administration in First-Tier Newborn Screening Assays.
Int J Neonatal Screen
December 2024
Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, S110-3, Atlanta, GA 30341, USA.
Parenteral nutrition (PN) is a nutrient solution administered intravenously (IV) to premature babies. PN causes elevations of some amino acids in blood samples that are also biomarkers used in newborn screening (NBS). Therefore, PN status must be annotated by clinicians on dried blood spot (DBS) cards to reduce NBS laboratory burdens associated with potential false results; however, NBS laboratories continue to receive DBSs with misannotated PN status.
View Article and Find Full Text PDFPrevalence and antimicrobial resistance of highly virulent cagA-positive Helicobacter pylori strains in Southern Poland.
Eur J Clin Microbiol Infect Dis
December 2024
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Street, Krakow, 30-688, Poland.
Purpose: Assessment of Helicobacter pylori (H. pylori) prevalence in Southern Poland, focusing on highly virulent cagA-positive strains associated with gastric cancer risk, along with analysis of antimicrobial resistance and its molecular mechanisms.
Methods: A total of 130 dyspeptic patients, who underwent endoscopy, were enrolled in the study.
Menstrual Blood as a Non-Invasive Alternative for Monitoring Vitamin Levels.
J Clin Med
November 2024
Orthopedic Clinic and Policlinic, Rostock University Medical Center, D-18057 Rostock, Germany.
: Menstrual blood has recently emerged as a novel specimen for diagnostics, offering a non-invasive alternative to traditional blood testing methods. Despite the importance of vitamins and monitoring their levels in preventative healthcare measures, the feasibility of measuring them in menstrual blood has yet to be explored. In this study, we aimed to assess the potential of using menstrual blood for determining vitamin levels by comparing their levels in menstrual blood to those in matched capillary blood samples.
View Article and Find Full Text PDFHIV phylogenetic clusters point to unmet hiv prevention, testing and treatment needs among men who have sex with men in kenya.
BMC Infect Dis
November 2024
Institute for Global Public Health, University of Manitoba, Winnipeg, Canada.
Article Synopsis
- The study investigates the HIV epidemic among gay, bisexual, and other men who have sex with men (GBMSM) in Kenya, emphasizing their disproportionate rates of infection and the need for tailored public health strategies.
- Researchers collected dried blood spots from 2,450 participants in different counties and found that 18.5% were living with HIV, with only a small number successfully sequenced due to high rates of viral suppression.
- Results indicated that the majority of identified HIV phylogenetic clusters involved GBMSM who sought partners online and tested less frequently than recommended, highlighting important gaps in HIV prevention and care within the community.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!